1![Clinical Guidelines Annals of Internal Medicine QTc Interval Screening in Methadone Treatment Mori J. Krantz, MD; Judith Martin, MD; Barry Stimmel, MD; Davendra Mehta, MD; and Mark C.P. Haigney, MD Clinical Guidelines Annals of Internal Medicine QTc Interval Screening in Methadone Treatment Mori J. Krantz, MD; Judith Martin, MD; Barry Stimmel, MD; Davendra Mehta, MD; and Mark C.P. Haigney, MD](https://www.pdfsearch.io/img/61b79355912a65429bb6728273db036d.jpg) | Add to Reading ListSource URL: annals.orgLanguage: English |
---|
2![Kentucky Department for Medicaid Services Drug Management Review Advisory Board (DMRAB) Recommendations for Consideration The following chart provides a summary of the final decisions made by the Department for Medicaid Kentucky Department for Medicaid Services Drug Management Review Advisory Board (DMRAB) Recommendations for Consideration The following chart provides a summary of the final decisions made by the Department for Medicaid](https://www.pdfsearch.io/img/65eacde05ec6ee5c7e5272fc34939173.jpg) | Add to Reading ListSource URL: kyportal.magellanmedicaid.comLanguage: English - Date: 2011-12-02 10:31:38
|
---|
3![Kentucky Department for Medicaid Services ProDUR Severity Level I Drug-to-Drug (DD) Interactions The following chart lists severity level I drug-to-drug interactions and recommendations for point-of-sale (POS) editing s Kentucky Department for Medicaid Services ProDUR Severity Level I Drug-to-Drug (DD) Interactions The following chart lists severity level I drug-to-drug interactions and recommendations for point-of-sale (POS) editing s](https://www.pdfsearch.io/img/dc7a887461d6656f0f0670526394fe83.jpg) | Add to Reading ListSource URL: kyportal.magellanmedicaid.comLanguage: English - Date: 2011-01-26 14:53:22
|
---|
4![Kentucky Department for Medicaid Services Drug Management Review Advisory Board (DMRAB) Recommendations for Consideration The following chart provides a summary of the recommendations that were made by the Drug Managemen Kentucky Department for Medicaid Services Drug Management Review Advisory Board (DMRAB) Recommendations for Consideration The following chart provides a summary of the recommendations that were made by the Drug Managemen](https://www.pdfsearch.io/img/76562984311bdc52aef61bd01e2d6930.jpg) | Add to Reading ListSource URL: kyportal.magellanmedicaid.comLanguage: English - Date: 2011-12-02 10:31:32
|
---|
5![Kentucky Department for Medicaid Services ProDUR Severity Level I Drug-to-Drug (DD) Interactions The following chart lists severity level I drug-to-drug interactions and recommendations for point-of-sale (POS) editing s Kentucky Department for Medicaid Services ProDUR Severity Level I Drug-to-Drug (DD) Interactions The following chart lists severity level I drug-to-drug interactions and recommendations for point-of-sale (POS) editing s](https://www.pdfsearch.io/img/7a63f3b707c73d3b085ca14390f1bad9.jpg) | Add to Reading ListSource URL: kyportal.magellanmedicaid.comLanguage: English - Date: 2011-04-22 13:12:22
|
---|
6![SPORANOX® (itraconazole) Capsules Congestive Heart Failure: SPORANOX® (itraconazole) Capsules should not be administered for the treatment of onychomycosis in patients with evidence of ventricular SPORANOX® (itraconazole) Capsules Congestive Heart Failure: SPORANOX® (itraconazole) Capsules should not be administered for the treatment of onychomycosis in patients with evidence of ventricular](https://www.pdfsearch.io/img/0e31224be12d3ffe80060596b9be136d.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2009-03-31 14:50:50
|
---|
7![SPORANOX® (itraconazole) Capsules BOXED WARNING Congestive Heart Failure, Cardiac Effects and Drug Interactions: SPORANOX® (itraconazole) Capsules should not be administered for the treatment of SPORANOX® (itraconazole) Capsules BOXED WARNING Congestive Heart Failure, Cardiac Effects and Drug Interactions: SPORANOX® (itraconazole) Capsules should not be administered for the treatment of](https://www.pdfsearch.io/img/f26a9188e77c067098747553205f9237.jpg) | Add to Reading ListSource URL: www.janssenpharmaceuticalsinc.comLanguage: English - Date: 2014-07-23 16:45:50
|
---|
8![0 (#I@Bristol-Myers Squibb Company Richard L. W uth, Ph.D. Senior Vice President 0 (#I@Bristol-Myers Squibb Company Richard L. W uth, Ph.D. Senior Vice President](https://www.pdfsearch.io/img/8a44d5ccf6276e82d20cacfea8bd49a5.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2005-01-05 16:25:56
|
---|
9![MEDICATION GUIDE TIKOSYN® (Tee’ ko sin) (dofetilide) Capsules Read the Medication Guide before you start taking TIKOSYN and each time you get a refill. This information does not take the place of talking with your doc MEDICATION GUIDE TIKOSYN® (Tee’ ko sin) (dofetilide) Capsules Read the Medication Guide before you start taking TIKOSYN and each time you get a refill. This information does not take the place of talking with your doc](https://www.pdfsearch.io/img/f073e520dc167ff40511624f76cbc001.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
10![Title/drp--author: [removed]—Packer, DL Title/drp--author: [removed]—Packer, DL](https://www.pdfsearch.io/img/4d6abae516bdbff74a8a3081c62f16ee.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|